Innovent Receives Approval of Dovbleron® (Taletrectinib Adipate Capsule, Ros1 Inhibitor) by China's National Medical Products Administration
Innovent获得中国国家医疗产品监督管理局对Dovbleron®(塔雷特克尼布阿迪帕特胶囊,Ros1抑制剂)的批准
Innovent Receives Approval of Dovbleron® (Taletrectinib Adipate Capsule, Ros1 Inhibitor) by China's National Medical Products Administration
Innovent获得中国国家医疗产品监督管理局对Dovbleron®(塔雷特克尼布阿迪帕特胶囊,Ros1抑制剂)的批准
使用浏览器的分享功能,分享给你的好友吧